Home
Forms Library
Skyrizi enrollment form

Skyrizi enrollment form 2026

skyrizi enrollment form Preview on Page 1

See details

4.7 out of 5

39 votes

The document outlines the AbbVie Patient Assistance Program for SKYRIZITM (rizankizumab-rzaa), which provides eligible patients with free access to AbbVie medications if they face financial difficulties. It includes a checklist for application submission, detailing sections for prescriber and patient information, financial documentation, insurance details, and consent requirements. The program aims to assist patients without charging fees and ensures confidentiality of personal data while determining eligibility.

Here's how it works

01. Edit your skyrizi enrollment form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send skyrizi enrollment form 2024 via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out skyrizi enrollment form with our platform

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Click ‘Get Form’ to open the skyrizi enrollment form in the editor.
Begin with Section 1, where prescribers should enter their information including name, office details, and shipping preferences.
In Section 2, provide patient history and diagnosis. Ensure all relevant medical conditions are accurately listed.
Complete Section 3 by entering the prescription details. Specify dosage and quantity as per the treatment plan.
Prescribers must sign and date in Section 4 to certify the prescription is accurate and necessary.
If you are a patient, proceed to Section 5 to fill out your personal information including name, date of birth, and contact details.
In Section 6, disclose financial and medical information. Attach proof of income as required.
Section 7 requires insurance information; include copies of your insurance cards if applicable.
Review and sign Section 8 for patient consent, ensuring you understand the privacy notice provided on Page 4.
Finally, keep a copy for your records before faxing or mailing the completed application to AbbVie.

Start using our platform today for free to simplify your skyrizi enrollment process!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

How do I sign my skyrizi complete enrollment form without printing?

Electronic signatures are a great replacement for traditional signing, as they save time, effort, and money people spend on printing, scanning, and paper delivery. You can electronically sign your skyrizi complete enrollment form utilizing a reliable and powerful online document processing tool like DocHub. It complies with primary eSignature standards (ESIGN and UETA), so all documents approved there are legally binding and have the same validity as manually signed ones.

How do you edit skyrizi enrollment form 2025 on iOS?

You can easily edit fill out your skyrizi enrollment form 2025 on any iOS gadget. Open an internet browser of your liking, go to the DocHub site, authorize or create a new account, add your file for editing, and make your required changes. Our service is mobile-friendly, so utilizing its functions on your phone will be a no-brainer, even on the first try.

Is SKYRIZI worth it?

Skyrizi has an average rating of 6.9 out of 10 from a total of 25 reviews on Drugs.com. 67% of reviewers reported a positive experience, while 29% reported a negative experience.

What is SKYRIZI prescribed for?

SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

Is SKYRIZI a specialty drug?

SKYRIZI is broadly available via open distribution, and prescriptions may be sent to the Specialty Pharmacy of the patients choosing. Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

skyrizi enrollment form pdf

Skyrizi Complete enrollment form pdf SKYRIZI enrollment form Dermatology SKYRIZI enrollment form Crohn's SKYRIZI enrollment form psoriasis Skyrizi enrollment form 2025 Skyrizi enrollment form 2025 pdf SKYRIZI patient assistance form pdf SKYRIZI enrollment form 2025 psoriasis

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more

Is SKYRIZI an expensive drug?

$987.00 - $3,530.00 per dose, depending on coverage phase. Represents catastrophic phase SKYRIZI cost. Out-of-pocket cost for SKYRIZI may vary depending on patients other medication costs.

Why is SKYRIZI so expensive?

Biologic drugs can be expensive because of the research and testing needed to ensure their safety and effectiveness. The drugmaker of a biologic can sell it for up to 12 years .

What is the cost of SKYRIZI kit?

The list price, also known as the Wholesale Acquisition Cost (WAC), for one dose of SKYRIZI is $19,734.61 as of January 3, 2023. The WAC may not reflect the price paid by patients. Call 1.866. SKYRIZI (1.866.

What class of drug is SKYRIZI?

Generic Name: risankizumab-rzaa Risankizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-23) that may cause inflammation and swelling.

What is the most expensive psoriasis drug?

Results: Secukinumab is the most expensive biologic with a 3-year cost of $182,718 compared with a 3-year cost of $5,000 for phototherapy.